Literature DB >> 15854807

Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium.

Mojca Kerec1, Marija Bogataj, Peter Veranic, Ales Mrhar.   

Abstract

Chitosan is a cationic polysaccharide widely employed as an absorption enhancer. The aim of this work was to examine the effect of chitosan on the permeability of isolated pig urinary bladder wall as well as to determine the role of calcium ions in this process. Besides permeability studies, scanning electron microscopy and fluorescent microscopy were applied to get an insight into the mechanism by which chitosan increases the permeability of urinary bladder wall. Additionally, the obtained findings were compared to the mechanism proposed for Caco-2 cells. The results show that 0.5% (w/v) chitosan increases the permeability of urinary bladder wall by causing the desquamation of the urothelium. Calcium ions, when applied to the luminal surface of the urinary bladder at the same time as chitosan, decreases the effect of chitosan on permeation of the model drug moxifloxacin into the bladder wall in concentration dependent way. The desquamation of urothelium cells caused by chitosan was reduced in the presence of calcium, but not to such extent as it would be expected from the permeability studies. When present, calcium obviously interferes directly in the interactions between chitosan and the surface of urothelium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15854807     DOI: 10.1016/j.ejps.2005.02.003

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  14 in total

1.  Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

Authors:  David A Zaharoff; Benjamin S Hoffman; H Brooks Hooper; Compton J Benjamin; Kiranpreet K Khurana; Kenneth W Hance; Connie J Rogers; Peter A Pinto; Jeffrey Schlom; John W Greiner
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

2.  Rapid differentiation of superficial urothelial cells after chitosan-induced desquamation.

Authors:  Peter Veranic; Andreja Erman; Mojca Kerec-Kos; Marija Bogataj; Ales Mrhar; Kristijan Jezernik
Journal:  Histochem Cell Biol       Date:  2008-09-17       Impact factor: 4.304

3.  Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.

Authors:  Andreja Erman; Veronika Križan Hergouth; Matthew G Blango; Mojca Kerec Kos; Matthew A Mulvey; Peter Veranic
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

4.  Correlative study of functional and structural regeneration of urothelium after chitosan-induced injury.

Authors:  Andreja Erman; Mojca Kerec Kos; Simon Žakelj; Nataša Resnik; Rok Romih; Peter Veranič
Journal:  Histochem Cell Biol       Date:  2013-04-04       Impact factor: 4.304

5.  Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.

Authors:  Angela Lopedota; Annalisa Cutrignelli; Valentino Laquintana; Nunzio Denora; Rosa Maria Iacobazzi; Mara Perrone; Elisabetta Fanizza; Maria Mastrodonato; Donatella Mentino; Antonio Lopalco; Nicoletta Depalo; Massimo Franco
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

6.  The complete functional recovery of chitosan-treated biomimetic hyperplastic and normoplastic urothelial models.

Authors:  Tanja Višnjar; Mateja Erdani Kreft
Journal:  Histochem Cell Biol       Date:  2014-08-27       Impact factor: 4.304

Review 7.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

8.  Permeation enhancer-containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery.

Authors:  Tsong-Long Hwang; Chia-Lang Fang; Chao-Huang Chen; Jia-You Fang
Journal:  Pharm Res       Date:  2009-08-04       Impact factor: 4.200

9.  Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs.

Authors:  Matthew G Blango; Elizabeth M Ott; Andreja Erman; Peter Veranic; Matthew A Mulvey
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 10.  The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer.

Authors:  Laura Douglass; Mark Schoenberg
Journal:  Bladder Cancer       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.